271 related articles for article (PubMed ID: 25432823)
1. Changes in adjuvant therapy utilization in stage I seminoma: are they enough to prevent overtreatment?
Kohut RM; Minnillo BJ; Kypriotakis G; Abouassaly R; Zhu H
Urology; 2014 Dec; 84(6):1319-24. PubMed ID: 25432823
[TBL] [Abstract][Full Text] [Related]
2. Management of clinical stage I testicular pure seminoma. Report on 42 patients and review of the literature.
Porcaro AB; Antoniolli SZ; Schiavone D; Maffei N; Bassetto MA; Curti P
Arch Ital Urol Androl; 2002 Jun; 74(2):77-80. PubMed ID: 12161941
[TBL] [Abstract][Full Text] [Related]
3. Management of stage I testicular seminoma over a period of 49 years.
Detti B; Scoccianti S; Villari D; Cipressi S; Sardaro A; Simontacchi G; Livi L; Gacci M; Cai T; Greto D; Desideri I; Biti G
Onkologie; 2011; 34(10):510-4. PubMed ID: 21985849
[TBL] [Abstract][Full Text] [Related]
4. [Surveillance of stage I testicular seminoma: 20 years oncological results].
Zores T; Mouracade P; Duclos B; Saussine C; Lang H; Jacqmin D
Prog Urol; 2015 Apr; 25(5):282-7. PubMed ID: 25724863
[TBL] [Abstract][Full Text] [Related]
5. Management of seminomatous testicular cancer: a binational prospective population-based study from the Swedish norwegian testicular cancer study group.
Tandstad T; Smaaland R; Solberg A; Bremnes RM; Langberg CW; Laurell A; Stierner UK; Ståhl O; Cavallin-Ståhl EK; Klepp OH; Dahl O; Cohn-Cedermark G
J Clin Oncol; 2011 Feb; 29(6):719-25. PubMed ID: 21205748
[TBL] [Abstract][Full Text] [Related]
6. [Long-term outcome of testicular seminoma in 294 patients].
Song Y; Yang L; Ma JH; Liu XF; Wang JW
Zhonghua Zhong Liu Za Zhi; 2008 Aug; 30(8):626-9. PubMed ID: 19102945
[TBL] [Abstract][Full Text] [Related]
7. Testis cancer: a 20-year epidemiological review of the experience at a regional military medical facility.
Cooper DE; L'esperance JO; Christman MS; Auge BK
J Urol; 2008 Aug; 180(2):577-81; discussion 581-2. PubMed ID: 18554661
[TBL] [Abstract][Full Text] [Related]
8. Clinical Characteristics and Outcomes of Late Relapse in Stage I Testicular Seminoma.
Hosni A; Warde P; Jewett M; Bedard P; Hamilton R; Moore M; Nayan M; Huang R; Atenafu EG; O'Malley M; Sweet J; Chung P
Clin Oncol (R Coll Radiol); 2016 Oct; 28(10):648-54. PubMed ID: 27339401
[TBL] [Abstract][Full Text] [Related]
9. Management and outcomes of clinical stage IIA/B seminoma: Results from the National Cancer Data Base 1998-2012.
Paly JJ; Lin CC; Gray PJ; Hallemeier CL; Beard C; Sineshaw H; Jemal A; Efstathiou JA
Pract Radiat Oncol; 2016; 6(6):e249-e258. PubMed ID: 27345128
[TBL] [Abstract][Full Text] [Related]
10. Treatment burden in stage I seminoma: a comparison of surveillance and adjuvant radiation therapy.
Leung E; Warde P; Jewett M; Panzarella T; O'Malley M; Sweet J; Moore M; Sturgeon J; Gospodarowicz M; Chung P
BJU Int; 2013 Dec; 112(8):1088-95. PubMed ID: 23937685
[TBL] [Abstract][Full Text] [Related]
11. Observation versus adjuvant radiation or chemotherapy in the management of stage I seminoma: clinical outcomes and prognostic factors for relapse in a large US cohort.
Soper MS; Hastings JR; Cosmatos HA; Slezak JM; Wang R; Lodin K
Am J Clin Oncol; 2014 Aug; 37(4):356-9. PubMed ID: 23275274
[TBL] [Abstract][Full Text] [Related]
12. Oncological outcomes in patients with stage I testicular seminoma and nonseminoma: pathological risk factors for relapse and feasibility of surveillance after orchiectomy.
Kobayashi K; Saito T; Kitamura Y; Nobushita T; Kawasaki T; Hara N; Takahashi K
Diagn Pathol; 2013 Apr; 8():57. PubMed ID: 23566361
[TBL] [Abstract][Full Text] [Related]
13. Management of Stage II testicular seminoma over a period of 40 years.
Detti B; Livi L; Scoccianti S; Gacci M; Lapini A; Cai T; Meattini I; Mileo AM; Iannalfi A; Bruni A; Biti G
Urol Oncol; 2009; 27(5):534-8. PubMed ID: 18848787
[TBL] [Abstract][Full Text] [Related]
14. Overall survival analysis of adjuvant radiation versus observation in stage I testicular seminoma: a surveillance, epidemiology, and end results (SEER) analysis.
Jones G; Arthurs B; Kaya H; Macdonald K; Qin R; Fairbanks RK; Lamoreaux WT; Jawed I; Tward JD; Martincic D; Shivnani AT; Lee CM
Am J Clin Oncol; 2013 Oct; 36(5):500-4. PubMed ID: 22781383
[TBL] [Abstract][Full Text] [Related]
15. Long term results and morbidity of paraaortic compared with paraaortic and iliac adjuvant radiation in clinical stage I seminoma.
Melchior D; Hammer P; Fimmers R; Schüller H; Albers P
Anticancer Res; 2001; 21(4B):2989-93. PubMed ID: 11712799
[TBL] [Abstract][Full Text] [Related]
16. A nationwide cohort study of stage I seminoma patients followed on a surveillance program.
Mortensen MS; Lauritsen J; Gundgaard MG; Agerbæk M; Holm NV; Christensen IJ; von der Maase H; Daugaard G
Eur Urol; 2014 Dec; 66(6):1172-8. PubMed ID: 25064686
[TBL] [Abstract][Full Text] [Related]
17. Management trends in stage I testicular seminoma: Impact of race, insurance status, and treatment facility.
Gray PJ; Lin CC; Sineshaw H; Paly JJ; Jemal A; Efstathiou JA
Cancer; 2015 Mar; 121(5):681-7. PubMed ID: 25345675
[TBL] [Abstract][Full Text] [Related]
18. Adjuvant radiation therapy in stage I seminoma: 20 years of oncologic results.
De Felice F; Musio D; Gravina GL; Marampon F; Tombolini V
Oncotarget; 2016 Nov; 7(48):80077-80082. PubMed ID: 27556300
[TBL] [Abstract][Full Text] [Related]
19. Management of Low-Stage Testicular Seminoma.
Pearce SM; Liauw SL; Eggener SE
Urol Clin North Am; 2015 Aug; 42(3):287-98. PubMed ID: 26216816
[TBL] [Abstract][Full Text] [Related]
20. Carboplatin in clinical stage I seminoma: too much and too little at the same time.
Bosl GJ; Patil S
J Clin Oncol; 2011 Mar; 29(8):949-52. PubMed ID: 21282532
[No Abstract] [Full Text] [Related]
[Next] [New Search]